Tilray, Inc. Business Finance Contracts & Agreements

69 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Equity Distribution Agreement, dated as of May 17, 2024, by and among Tilray Brands, Inc. and TD Securities (USA) LLC and Jefferies LLC
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Amended and Restated Credit Agreement, dated as of March 14, 2024, by and among Aphria Diamond Inc., Aphria Inc., the Company, Bank of Montreal and the Guarantors and Lenders...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2024
Third Amendment and Consent to Credit Agreement, dated as of March 29, 2024, by and among American Beverage Crafts Group, Inc. (formerly known as Four Twenty Corporation), Bank of...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Promissory note in the amount of $26,134,500 payable by 1945689 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2024
Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto (incorporated...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Waiver to Credit Agreement, dated as of January 5, 2024, by and between Four Twenty Corporation, Bank of America, N.A., and the Guarantors and Lenders party thereto
Credit Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Promissory note in the amount of $8,057,622 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Second Amendment and Consent to Credit Agreement, dated as of September 29, 2023
Credit Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
First Amendment to Securities and Asset Purchase Agreement, dated as of September 29, 2023
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
2023
Purchase Agreement, dated August 7, 2023, by and among Tilray,Anheuser-Busch Companies, LLC, Craft USA Holdings, LLC, Craft Brew Alliance, Inc. and Tilray Beverages, LLC
Purchase Agreements
Tilray, Inc.
Pharmaceuticals
WA
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and TSX Trust Company
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2023
Third Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2023
Second Supplemental Warrant Indenture dated June 22, 2023 among HEXO Corp., Tilray Brands, Inc. and Computershare Trust Company of Canada
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
2023
Waiver and Amendment Agreement, dated as of June 1, 2023, by and between Tilray and HEXO
Waiver Agreements
Tilray, Inc.
Pharmaceuticals
2023
Share Lending Agreement, dated May 25, 2023, between Tilray Brands, Inc. and Jefferies Capital Services, LLC
Share Agreements
Tilray, Inc.
Pharmaceuticals
NY
2023
First Supplemental Indenture, dated May 31, 2023, between Tilray Brands, Inc. and Computershare Trust Company, N.A
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Indenture, dated May 31, 2023, between Tilray Brands, Inc. and Computershare Trust Company, N.A
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
DE
2023
Underwriting Agreement, dated May 25, 2023, by and among Tilray Brands, Inc. and Jefferies LLC and BofA Securities, Inc., as representatives of the several underwriters named...
Underwriting Agreements
Tilray, Inc.
Pharmaceuticals
DC
2023
Promissory note in the amount of $6,648,304 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $9,264,249.68 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $8,464,139.70 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Promissory note in the amount of $30,585,819.60 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2023
Assignment and Assumption Agreement, dated September 1, 2022, between Double Diamond Holdings Ltd., and Tilray Brands, Inc
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2023
Amended and Restated Credit Agreement, dated as of November 28, 2022, by and among 1974568 Ontario Limited, Aphria Inc., Tilray Brands, Inc., Bank of Montreal as agent and the...
Credit Agreements
Tilray, Inc.
Pharmaceuticals
2022
Promissory note in the amount of $5,063,709.00 payable by 1974568 Ontario Limited
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Assignment and Assumption Agreement, dated June 30, 2022, between Double Diamond Holdings Ltd., and Tilray Brands, Inc
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Indenture dated as of May 27, 2021, by and between HEXO Corp. as issuer, and GLAS Trust Company LLC, as trustee
Indenture Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Amended and Restated Senior Secured Convertible Note due 2026, dated July 12, 2022, issued and owing by HEXO to the Company
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Convertible Promissory Note due September 1, 2023, dated July 12, 2022, issued and owing by the Company to HTI
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Amending Agreement to Amended and Restated Assignment and Assumption Agreement dated as of July 12, 2022, by and among the Company, HTI and HEXO
Assignment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Form of Convertible Note due September 1, 2023, issued and owing by the Company to HTI
Note Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022
Amended and Restated Assignment and Assumption Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO
Investment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Amending Agreement to Transaction Agreement, dated as of June 14, 2022, by and among the Company, HT Investments MA LLC and HEXO
Investment Agreements
Tilray, Inc.
Pharmaceuticals
NY
2022
Form of Amended and Restated Senior Secured Convertible Note due 2026, issued and owing by HEXO Corp. to the Company
Note Agreements
Tilray, Inc.
Pharmaceuticals
2022
Assignment and Assumption Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp
Investment Agreements
Tilray, Inc.
Pharmaceuticals
2022
Transaction Agreement, dated as of April 11, 2022, by and among the Company, HT Investments MA LLC and HEXO Corp
Investment Agreements
Tilray, Inc.
Pharmaceuticals
DE
2022